Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Ludovic, Evesque"'
Autor:
Stefano Kim, Jihane Boustani, Dewi Vernerey, Véronique Vendrely, Ludovic Evesque, Eric Francois, Laurent Quero, Francois Ghiringhelli, Christelle de la Fouchardière, Laëtitia Dahan, Oliver Bouché, Benoist Chibaudel, Farid El Hajbi, Chloé Vernet, Magali Rebucci-Peixoto, Alexandra Feuersinger, Christophe Maritaz, Christophe Borg
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundChemoradiotherapy alone is the standard treatment for locally advanced squamous cell anal carcinoma (SCAC). However, up to 50% of patients will experience recurrence; thus, there is a need for new treatments to improve outcomes. Modified do
Externí odkaz:
https://doaj.org/article/08ac6218fcf8493fbfa42d7f8be1d2e4
Autor:
Antoine Adenis, Thibault Mazard, Julien Fraisse, Patrick Chalbos, Brice Pastor, Ludovic Evesque, Francois Ghiringhelli, Caroline Mollevi, Stéphanie Delaine, Marc Ychou
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background The chemotherapy triplet FOLFOXIRI combined to the anti-VEGF antibody bevacizumab is an option in selected patients with metastatic colorectal cancer. In this setting, RAS-mutated metastatic colorectal cancer do not benefit the sa
Externí odkaz:
https://doaj.org/article/17e448b14f574e0c99aced3091049c7c
Autor:
Karen Benezery, Lucile Montagne, Ludovic Evesque, Renaud Schiappa, Jean-Michel Hannoun-Levi, Eric Francois, Brice Thamphya, Jean-Pierre Gerard
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 24, Iss , Pp 92-98 (2020)
Introduction: A neoadjuvant treatment aimed at rectal preservation should achieve a clinical complete response. This study comparing neoadjuvant treatment initiated with Contact X-ray (CXB) or External Beam radiotherapy (EBRT) is evaluating the influ
Externí odkaz:
https://doaj.org/article/6631fadf27ea4b07bb11ed88e6737d3b
Autor:
Angélique Saint, Ludovic Evesque, Alexander T. Falk, Gérard Cavaglione, Lucile Montagne, Karen Benezery, Eric Francois
Publikováno v:
Cancer Medicine, Vol 8, Iss 16, Pp 6853-6859 (2019)
Abstract Background Metastatic squamous cell carcinomas (SCC) of the anal canal are rare and there is no international consensus on their second‐line management. 5‐Fluorouracil (5‐FU) and mitomycin in combination with radiotherapy is the standa
Externí odkaz:
https://doaj.org/article/3b00e3c7bb924063818f067ec740e1a5
Autor:
Emilien Bertin, Karen Benezery, Daniel Lam Cham Kee, Eric François, Ludovic Evesque, Mathieu Gautier, Jean-Pierre Gerard, Jean-Michel Hannoun-Levi, Alexander T Falk
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 10, Iss 6, Pp 522-531 (2018)
Externí odkaz:
https://doaj.org/article/3c59d54356b54a6e979877f016447322
Autor:
David Piquemal, Roman Bruno, Barbara Bournet, Francois Ghiringhelli, Florian Noguier, Cindy Canivet, Aurélie Bertaut, Fabien Pierrat, Ludovic Evesque, Amelia Gamez, Jerome Cros, Emilie Rederstorff, Erwan Petit, Johan Adnet, Angélique Saint, Antoine Drouillard, Emmanuelle Kempf, Emilie Soularue, Julie Vincent, Isabelle Baumgaertner, Audrey Hennequin, Christophe Tournigand, Daniel Lopez Trabada Ataz, Leila Bengrine, Come Lepage, Sylvain Manfredi, Pauline Afchain, Isabelle Trouilloud, Alice Gagnaire, Noelle K. LoConte, Jean-Baptiste Bachet
Publikováno v:
Journal of Gastrointestinal Oncology. 14:997-1007
Autor:
Thierry, Conroy, Florence, Castan, Anthony, Lopez, Anthony, Turpin, Meher, Ben Abdelghani, Alice C, Wei, Emmanuel, Mitry, James J, Biagi, Ludovic, Evesque, Pascal, Artru, Thierry, Lecomte, Eric, Assenat, Lucile, Bauguion, Marc, Ychou, Olivier, Bouché, Laure, Monard, Aurélien, Lambert, Pascal, Hammel, Chris, O'Callaghan
Publikováno v:
JAMA oncology. 8(11)
ImportanceEarly results at 3 years from the PRODIGE 24/Canadian Cancer Trials Group PA6 randomized clinical trial showed survival benefits with adjuvant treatment with modified FOLFIRINOX vs gemcitabine in patients with resected pancreatic ductal ade
Autor:
Julien Taieb, Jean-François Emile, Pierre Laurent-Puig, David Tougeron, Clémence Toullec, Farid El Hajbi, Olivier Bouché, Hervé Perrier, Ludovic Evesque, Emilie Barbier, Thierry André, Jérémie Bez, Stefano Kim, Frédéric Di Fiore, Côme Lepage, Marion Chauvenet
Publikováno v:
Digestive and Liver Disease. 53:318-323
Immune checkpoint inhibitors have failed in treating metastatic colorectal cancer (mCRC) patients except those with dMMR/MSI tumors. However, until very recently we had only non-comparative promising data in this population with anti-programmed cell
Autor:
Emmanuelle Samalin, Hélène Senellart, Ludovic Evesque, Olivier Bouché, Faiza Khemissa, Christelle De La Fouchardiere, Anthony Lopez, Slimane Dermeche, Damien Botsen, David Tougeron, Aziz Zaanan, Meher BEN Abdelghani, Emmanuel Guardiola, Olivier Dubreuil, Valérie Le Brun Ly, Audrey Hennequin, Nicolas De Sousa Carvalho, Florence Castan, Anthony Turpin
Publikováno v:
Journal of Clinical Oncology. 41:387-387
387 Background: Several options have been evaluated as 2nd line treatment in mGA after failure of 1st line platinum based chemotherapy including taxanes and IRI as monotherapies or paclitaxel combined with ramucirumab but with a limited efficacy. REG
Autor:
Jean-Michel Hannoun-Levi, Lucile Montagne, Renaud Schiappa, Jean-Pierre Gerard, Eric Francois, Karen Benezery, B. Thamphya, Ludovic Evesque
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 24, Iss, Pp 92-98 (2020)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Elsevier, 2020, 24, pp.92-98. ⟨10.1016/j.ctro.2020.07.001⟩
Clinical and Translational Radiation Oncology, 2020, 24, pp.92-98. ⟨10.1016/j.ctro.2020.07.001⟩
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Elsevier, 2020, 24, pp.92-98. ⟨10.1016/j.ctro.2020.07.001⟩
Clinical and Translational Radiation Oncology, 2020, 24, pp.92-98. ⟨10.1016/j.ctro.2020.07.001⟩
Highlights • Treatment initiation of T2-T3 rectal cancers with Contact (CXB) provides a fast clinical complete response. • In T2N0< 3 cm tumors, CXB first with chemoradiotherapy can achieve local control in more than 85%. • The Phase III OPERA